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Rocha et al. demonstrate an increased
frequency of activated neutrophils and
low-density granulocytes in P. vivax
patients. The activation stage of
neutrophils was associated with a type I
IFN transcriptional signature.
Importantly, IFNAR and caspase 1/11
were shown to play a central role in
neutrophil recruitment and liver damage
in rodent malaria.
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SUMMARY
Neutrophils are the most abundant leukocyte popu-
lation in the bloodstream, the primary compartment
of Plasmodium sp. infection. However, the role of
these polymorphonuclear cells in mediating either
the resistance or the pathogenesis of malaria is
poorly understood.We report that circulating neutro-
phils from malaria patients are highly activated, as
indicated by a strong type I interferon transcriptional
signature, increased expression of surface activation
markers, enhanced release of reactive oxygen spe-
cies and myeloperoxidase, and a high frequency
of low-density granulocytes. The activation of neu-
trophils was associated with increased levels of
serum alanine and aspartate aminotransferases,
indicating liver damage. In a rodent malaria model,
we observed intense recruitment of neutrophils to
liver sinusoids. Neutrophil migration and IL-1b and
chemokine expression as well as liver damage were
all dependent on type I interferon signaling. The
data suggest that type I interferon signaling has
a central role in neutrophil activation and malaria
pathogenesis.
INTRODUCTION
Malaria infected approximately 200 million people in 2013, and
an estimated 584,000 of these people died (World Health Orga-
nization, 2014). Plasmodium vivax is the most widespread hu-
man Plasmodium species and represents a major social and
economic health problem, especially in Latin America and Asia
(Mueller et al., 2009; World Health Organization, 2014). On the
other hand, Plasmodium falciparum is more prevalent in Africa
and is responsible for most of the deaths from malaria (World
Health Organization, 2014). Although the pathology associated
with malaria occurs during the erythrocytic stage of infection,
the liver is an important organ for malaria infection, because
Plasmodium infects hepatocytes early in its life cycle, where it
replicates asexually before reaching the blood stage (Prude^ncio
et al., 2006; Sturm et al., 2006). Furthermore, the liver is also an
important organ for the trapping and clearance of Plasmodium-
infected red blood cells (Kr€ucken et al., 2009; Murthi et al.,
2006). As a result, there is an intense recruitment of leukocytes
to the liver during the acute phase of malaria (Haque et al., 2011).
The complexity of parasite-host interactions and the limited
knowledge of the mechanisms by which Plasmodium spp.
trigger innate immune cells are the main impediments in under-
standing the pathogenesis of malaria (Gazzinelli et al., 2014).
Surprisingly, the role of neutrophils in malaria has rarely been
addressed.
Neutrophils are polymorphonuclear leukocytes (PMNs)
capable of eliminating bacterial and fungal infections by multiple
mechanisms (Mantovani et al., 2011). In addition to being the
primary effectors of the immune response against microbial
pathogens, neutrophils are also central mediators of inflamma-
tory injury. However, the role of neutrophils in host resistance
and pathogenesis of malaria is still controversial. Nevertheless,
an altered function of neutrophils has been reported in both
P. vivax and P. falciparummalaria (Cunnington et al., 2012; Leor-
atti et al., 2012).
Type I interferons (IFNs) are cytokines that play an important
role in the protection against viral infections. Type I interferons
possess strong immunomodulatory activity. The production of
type I IFNs has been associated with many other pathogens,
including Mycobacterium (Antonelli et al., 2010), Leishmania
(Xin et al., 2010), and Plasmodium (Aucan et al., 2003; Haque
et al., 2014; Sharma et al., 2011). Type I IFNs modulate macro-
phages, monocytes, dendritic cells, and neutrophils through
many different mechanisms (Salazar-Mather et al., 2002; Seo
et al., 2011; Swiecki et al., 2011). Despite the high frequency of
malaria, the roles of type I IFN in regulating neutrophils during
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infection have not been explored. Therefore, we decided to
focus on the importance of type I IFN in orchestrating neutrophil
activation and function during malaria. We found that, in both
human and rodent malaria, neutrophil activation by type I IFN
is associated with increased levels of circulating transaminases,
indicative of liver pathology. Furthermore, we found that type I
IFN modulates caspase-1/11 activation, pro-interleukin 1b
(pro-IL-1b), and chemokine mRNA expression as well as neutro-
phil migration to the livers of infected mice. Together, our results
suggest that type I IFNs are responsible for neutrophil-mediated
liver pathology during human and rodent malaria.
RESULTS
Neutrophils from P. vivax-Infected Patients Are Highly
Activated
We observed an increase in the frequency and absolute number
of neutrophils in the peripheral blood of P. vivax-infected pa-
tients (Figure 1A). To obtain these results, we used CD66b
and CD15 as neutrophil markers. As shown in Figures S1A
and S1B, more than 98% of neutrophils from malaria patients
expressed both markers. We also observed a low frequency
of neutrophils containing hemozoin in blood smears of
P. vivax-infected patients (Figure 1B, left). The arrows in the
center indicate parasites and hemozoin (Hz) inside neutrophil
vacuoles after 30 min of in vitro incubation with P. vivax-infected
reticulocytes (PvRETs). Preparations of enriched PvRETs are
shown in Figure 1B (right). To evaluate their activation status,
we assessed the kinetics of reactive oxygen species (ROS) pro-
duction after stimulation with phorbol 12-myristate 13-acetate
(PMA) and with PvRETs. Total ROS production was evaluated
in purified neutrophils by luminol assay. Neutrophils from
acutely infected patients produced significantly higher levels
of ROS than neutrophils from healthy donors (HDs) when
stimulated with PMA. These differences persisted over 1 hr of
stimulation. Pre-treating cells with a nicotinamide adenine
Figure 1. Neutrophils from P. vivax-Infected Patients Display a Highly Activated Phenotype
(A) Frequency (top) and absolute numbers (bottom) of neutrophils stained within whole blood from P. vivax-infected patients before and 30–45 days after
treatment (After Rx). Each pair of circles connected by a line represents a single patient (n = 11). The absolute numbers were calculated based on their frequency
and total leukocytes numbers. Dashed lines represent the median of given measurements for five healthy donors.
(B) Left: neutrophils containing hemozoin (yellow arrows) from P. vivax-infected patient blood smears. Center: parasite components and hemozoin in vacuoles
(black arrows) of neutrophils after in vitro incubationwith PvRETs (asterisks). Right: enriched PvRETs fromperipheral blood ofmalaria patients by Percoll gradient.
(C) Thekinetics ofROSproductionby neutrophils frompatientswith acuteP. vivax infectionorHDscultured inmediumaloneorwith 100ng/ml PMA in thepresence
or absence of the ROS inhibitor DPI (5 mM) (n = 5–7) (left) or stimulated with purified PvRETs (neutrophil:PvRET ratio, 2:1) (n = 4) (right). Luminol was measured
by chemiluminescence (relative light units [RLUs]) for 60min. Data are represented asmean±SEM. The differences are relative to HDs. *p < 0.05, **p < 0.01, ****p <
0.0001. Individual values of PMA- or PvRET-induced ROSs released by neutrophils from P. vivax-infected patients and HDs are depicted in Figure S2.
(D) MPO levels in supernatants of unstimulated and PMA-activated (100 ng/ml) neutrophils from P. vivax-infected patients before and after treatment for 24 hr
(n = 11). Dashed lines represent the median of given measurements for five healthy donors.
See also Figures S1 and S2.
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dinucleotide phosphate (NADPH) oxidase inhibitor, diphenyle-
neiodonium chloride (DPI), completely abrogated ROS produc-
tion in neutrophils from P. vivax-infected patients as well as in
neutrophils from HDs. Similarly PvRETs also induced an
augmented ROS production by neutrophils from P. vivax-in-
fected patients (Figure 1C). We also measured myeloperoxidase
(MPO) production by these cells after 24 hr of stimulation with
PMA. Neutrophils from P. vivax-infected patients treated with
PMA released significantly higher levels of MPO than neutro-
phils from the same patients after chemotherapy or neutrophils
purified from HDs (Figure 1D). Together, these results indicate
that neutrophils are highly activated and become hyper-respon-
sive during P. vivax infection.
P. vivax Infection Induces an Increased Frequency of
Activated Low-Density Granulocytes in the Peripheral
Blood
Using conventional density gradient centrifugation to separate
peripheral blood mononuclear cells (PBMCs) from malaria-in-
fected patients, we found a higher frequency of a leukocyte sub-
set with a high side scatter height (SSC-H) compared with those
purified from healthy donors or cured patients (Figure 2A). We
subsequently found that the frequency of SSChiCD66b+CD16+
cells within PBMCs was significantly higher in P. vivax-infected
patients than in uninfected controls (Figure 2B). These cells did
not express CD14 or major histocompatibility complex (MHC)
class II molecules, confirming that they are not monocytes
Figure 2. Low-Density Granulocytes Are Increased and Activated in PBMCs from Patients with Acute P. vivax Infections
(A and B) Representative density plots (A) and bar graph (B) indicating the frequencies of SSChiCD66b+CD16+ (LDGs) within PBMCs of HDs (white circles) (n = 9)
and P. vivax-infected patients before (black circles, n = 21) and after treatment (gray circles, n = 14). Data are represented as mean ± SD. Numbers within or
beside each box refer to the cell frequencies within each gate (A).
(C) Top: representative histograms of CD66b, CD15, CD16, and CD11b of LDGs and neutrophils from P. vivax-infected patients and neutrophils from HDs gated
previously on SSChiCD66b+. Light gray histogram, neutrophils fromHDs; dark gray histogram, LDGs; white histogram, neutrophils fromP. vivax-infected patients.
Bottom: MFI scatterplots of the respective activation markers in LDGs (gray circles) and neutrophils (white circles) from P. vivax-infected patients and neutrophils
from HDs (dashed line). Each circle represents one patient (n = 9–16). Numbers within or beside each box refer to the cell frequencies within each gate.
(D) Representative zebra plot of CD34 and CD117 cell frequencies in LDGs and neutrophils from P. vivax-infected patients. Numbers within or beside each box
refer to the cell frequencies within each gate.
See also Figure S3.
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Figure 3. Functional Characterization of LDGs from P. vivax-Infected Patients
(A) Top: CFSE-labeled PBMCs fromP. vivax-infected patients after LDG purification stimulated with soluble aCD3 (1 mg/ml) and aCD28 (0.5 mg/ml) in the presence
or absence of LDGs or neutrophils (PBMC:LDG or neutrophil ratio, 2:1). After 4 days, CD4+ (left) and CD8+ (right) T cell proliferation was determined by flow
cytometry after gating the CD3+ population and measuring the percentage of CFSElow T cells. Bottom: percentage of CD4 and CD8 cell proliferation. Data are
presented as mean ± SD (n = 5).
(legend continued on next page)
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(Figure S3). Therefore, this leukocyte subset, which also ex-
presses CD15, was defined as low-density granulocytes
(LDGs) (Brandau et al., 2011; Denny et al., 2010).
We next investigated the expression of activation markers
within LDGs and neutrophils from 16 malaria patients as well
as neutrophils from HDs. We observed that the median fluores-
cence intensity (MFI) of CD15 and CD66b from LDGs of P. vivax-
infected patients was significantly higher than the MFI of these
markers on purified neutrophils. There was no observable differ-
ence in either CD16 or CD11b expression in LDGs versus PMNs
(Figure 2C). CD34 and CD117, markers expressed on early pro-
genitors, were not detected on either LDGs or neutrophils. Taken
together, the profile of surface molecular expression suggests
that LDGs are activated neutrophils that have degranulated dur-
ing P. vivax infection.
We next performed functional assays to determine the rele-
vance of LDGs in P. vivax infection. Because LDGs express
surface markers similar to granulocytic/neutrophilic myeloid-
derived suppressor cells (MDSCs) (Brandau et al., 2011;
Rodriguez et al., 2009), we tested their ability to inhibit T cell
proliferation. We found that neither LDGs nor neutrophils from
P. vivax-infected patients suppressed T cell proliferation after
stimulation with aCD3/aCD28 (Figure 3A). Furthermore, we
showed that LDGs have an impaired migration toward CCL3
or IL-8 even though the expression of chemokines receptors
was not reduced (Figure 3B). As we have shown previously,
themigration to IL-8 was reduced in neutrophils frommalaria pa-
tients (Leoratti et al., 2012). Interestingly, we observed that neu-
trophils from P. vivax-infected patients have an enhancedmigra-
tion capacity to CCL3. This was associated with an increased
expression of the chemokine receptor CCR5 (Figure 3B). Finally,
we observed that LDGs have increased phagocytic activity,
similar to neutrophils from malaria patients, compared with neu-
trophils fromHDs (Figure 3C). Unexpectedly, we found low levels
of phagocytosis of uninfected red blood cells (uRBCs) by LDGs
as well as neutrophils from malaria patients and healthy donors.
This background of our assay indicates low levels of internaliza-
tion of carboxyfluorescein succinimidyl ester (CFSE)-labeled
uRBCs that may have been damaged during the experimental
procedure. Nevertheless, the difference of phagocytosis be-
tween uRBCs and PvRETs is dramatic and indicates that in-
fected reticulocytes are indeed actively internalized by neutro-
phils and LDGs from P. vivax-infected patients.
Neutrophils Have an Interferon Transcriptional
Signature during P. vivax Infection
We next profiled mRNA expression of highly enriched neutro-
phils (>99% purity; Figure S4A) collected from ten P. vivax-in-
fected patients. We excluded the influence of significant mono-
cyte contamination in these neutrophil preparations because we
could not detect CD14+ cells in our preparation (Figure S4B). In
addition, we analyzed our preparations for cytokine transcripts,
including IFN-a and IFN-b as well as chemokines that are pro-
duced by monocytes and not neutrophils, and they were not de-
tected in this assay (Figure S4C). In agreement, different studies
indicate that neutrophils do not produce type I IFN (von der Ohe
et al., 2001; Yamaguchi et al., 1977). Furthermore, we assessed
the mRNA and protein levels of IL-1b by neutrophils and mono-
cytes from P. vivax-infected patients. Our results indicate that
malaria infection does not induce an upregulation of neutrophil
IL-1b transcripts and that these cells did not produce IL-1b after
LPS challenge (Figure S4D). A custom codeset for nanostring
analysis was designed, containing 98 genes related to inflamma-
tory responses. Of 66 genes that were expressed by neutrophils,
we found that 34 genes were differentially expressed upon
P. vivax infection with a fold change of more than 1.8 and a p
value of less than 0.05 compared with purified neutrophils from
the same patients after chemotherapy (Table S1). Of these 34
differentially expressed genes, 19 were considered to be IFN-
stimulated genes (ISGs) (Figure 4A).
To get a clearer idea of what constitutes a ‘‘type I IFN signa-
ture,’’ we purified neutrophils from HDs and stimulated them
with either type I IFN or type II IFN (IFN-g). We observed that
most of the ISGs highly induced during malaria were predomi-
nantly type I IFN-dependent, although IFN-g also stimulated
some of these genes but, generally, to a lesser extent (Figure 4B).
We also investigated ISG transcriptional expression in LDGs
from P. vivax-infected patients. ISG expression by LDGs was
lower than by neutrophils, suggesting that these cell populations
have different roles during malaria infection (Figure 4C). Finally,
we observed a positive correlation between ISGs and aspartate
(AST) serum levels in P. vivax-infected patients (Figure 4D). The
malaria patients enrolled in this study had significantly increased
levels of serum alanine (ALT) and AST aminotransferases
compared with the same patients after therapy (Figure S4E). In
summary, these data suggest that neutrophils from P. vivax-in-
fected patients have a predominantly type I IFN transcriptional
signature that correlates positively with liver damage.
Neutrophil Recruitment and Liver Damage in
Plasmodium chabaudi-Infected Mice
Based on the hypothesis that neutrophils may be triggering liver
damage during malaria, we investigated this phenomenon in
mice infected with the blood stage of P. chabaudi. We first
measured the recruitment of granulocytes on days 7, 11, and
14 post-infection by confocal intravital microscopy using anti-
GR1 (Figure 5A). These results were confirmed by using the
anti-Ly6G (clone 1A8) antibody, which is more specific for neu-
trophils (Movie S1). The success of infection was confirmed
by blood smears and by the presence of pigment (hemozoin)
found only in infected livers (Figure 5A). We counted an average
of 25.73 ± 4.69 (mean ± SEM) neutrophils per 103 field in
(B) Top: histograms and MFI of CCR5 and CXCR2 expression in neutrophils (n = 6) and LDGs (n = 5) from P. vivax-infected patients and neutrophils from HDs
(n = 5). Bottom: chemotaxis toward CCL3 (50 ng/ml) and IL-8 (10 ng/ml) evaluated in neutrophils and LDGs from P. vivax-infected patients (n = 5) and neutrophils
from HDs (n = 4). Data are presented as mean ± SD.
(C) Density plots (top) and bar graph (bottom) of neutrophils (n = 4) and LDGs (n = 3) from P. vivax-infected patients and neutrophils fromHDs (n = 3) cocultured for
1 hr with purified PvRETs or uRBCs stained with CFSE (neutrophil or LDG:PvRET or uRBC ratio, 2:1). The numbers within each box refer to the cell frequencies
within each gate. Data are represented as mean ± SEM. *p < 0.05, **p < 0.01.
Cell Reports 13, 2829–2841, December 29, 2015 ª2015 The Authors 2833
non-infected (NI) mice, whereas the mean of infected animals
increased to 177.9 ± 22.93, 204.7 ± 11.44, and 140.9 ± 3.99 neu-
trophils per 103 field of view (FOV) after 7, 11, and 14 days,
respectively (Figure 5B). The serum ALT levels were measured
in infected animals on different days and compared with the
levels of NI mice. We noticed that mice after 7, 11, and
14 days of P. chabaudi infection had significantly higher levels
of ALT than NI mice (Figure 5C). Because we observed the
Figure 4. Neutrophils Have an IFN Transcriptional Signature during Malaria Infection
(A) Nanostring analysis of purified neutrophils from ten patients with acute P. vivax infections before and after treatment. Shown is a heatmap representation of 32
differentially regulated genes uponmalaria infection. The heatmap shows normalized log2 ratios (P. vivax/after treatment) of differentially expressed genes (rows)
for each patient (columns).
(B) Heatmap representation of a selection of ISGs that were significantly inducible during malaria infection. Neutrophils from healthy donors were stimulated with
type I IFN (1000 U/ml) or IFN-g (100 ng/ml) for 2 hr, and their gene expression was normalized to unstimulated cells (n = 3). The heatmap shows normalized log2
ratios (type I IFN or IFN-g/unstimulated) of differentially expressed ISGs.
(C) mRNA counts normalized to seven housekeeping genes of LDGs (n = 7) and neutrophils (n = 5) fromP. vivax-infected patients. Shown is a heatmap of ISGs that
were differentially regulated upon malaria infection.
(D) LGP2/DHX58, VIPERIN, IRF5, TAP2,RIG-I, and IRF7mRNA counts from the nanostring analysis show a trend to correlate with AST serum levels from P. vivax-
infected patients. The results are expressed as scatterplots of individual values. Squares indicate individual patients (n = 9). Pearson’s rank correlation (r) and p
values are shown in the graphs.
See also Figure S4 and Table S1.
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Figure 5. Following P. chabaudi Infection, Neutrophils Are Recruited to the Liver and Induce Liver Damage
Cells were quantified by confocal intravital microscopy.
(A) Representative images of bright-field (bottom) and neutrophil staining with anti-GR1 (top) in liver sinusoids from NI and P. chabaudi-infected mice from
different days of infection (days 7, 11, and 14). Scale bars, 100 mM (top) and 200 mM (bottom).
(B) Absolute numbers of GR1-positive cells from at least four fields of view. The results are representative of two independent experiments (n = 4). ****p < 0.0001.
Data are represented as mean ± SEM.
(C) Serum ALT levels were measured on different days of P. chabaudi infection and in non-infected mice (n = 8). The differences are relative to non-infected mice.
*0.05 > p > 0.01; **0.01 > p > 0.001; ****p < 0.0001. Data are represented as mean ± SEM.
(D and E) Absolute neutrophil (CD11b+Ly6CintLy6G+) quantification by flow cytometry in peripheral blood (n = 8) (D) and in liver leukocytes (n = 5) (E) of NI and
P. chabaudi-infectedmice treatedwith anti-Ly6G (clone 1A8) or with an isotype control (clone 2A3). The data are relative from two independent experiments. Data
are represented as mean ± SEM.
(F) Representative images of Liver intravital microscopy of the neutrophil depletion experiment after 11 days of P. chabaudi infection. Cells were stained with anti-
GR1 (top) in mice treated with anti-Ly6G (clone 1A8) or left untreated. Bottom: bright-field image of the liver. Scale bars, 100 mM (top) and 200 mM (bottom).
(G) Quantification of GR1-positive cells from at least four fields of view (n = 3). Data are represented as mean ± SEM.
(H) Serum ALT levels were measured after 11 days of infection in mice treated with anti-Ly6G (clone 1A8) or with an isotype control (clone 2A3) (n = 8). Data are
represented as mean ± SEM.
(I) Parasitemia of P. chabaudi-infected mice treated with either anti-Ly6G or an isotype control was evaluated by Giemsa staining of a blood smear prepared on
different days post-infection. Data are represented as mean ± SEM.
See also Figure S5 and Movie S1.
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highest numbers of neutrophils as well as liver damage on day 11
after infection, we decided to use this time point for subsequent
experiments.
To check whether neutrophils were responsible for the
observed liver damage during P. chabaudi infection, we
depleted them by administering the anti-Ly6G monoclonal anti-
body (clone 1A8) to infected and NI animals. Cells were subse-
quently assessed by flow cytometry. We detected an 86%
and76% reduction of CD11b+Ly6CintLy6G+ cell population ab-
solute numbers in the peripheral blood and livers of infected
mice treated with anti-Ly6G, respectively (Figures 5D and 5E).
To confirm the specificity of neutrophil depletion, we analyzed
the frequency and absolute cell number of other leukocytes in
whole blood (Figure S5). We also assessed neutrophil depletion
in the liver by confocal microscopy (Figure 5F). On day 11
following infection, the mean neutrophil number per 103 field
was 278.9 ± 17.6 (±SEM) and 24.33 ± 4.1 inP. chabaudi-infected
mice treated with the isotype control and anti-Ly6G, respec-
tively. Uninfected animals showed similar neutrophil counts as
infected mice treated with anti-Ly6G (isotype control, 12.9 ±
2.7; anti-Ly6G, 25.6 ± 4.2) (Figure 5G). Most importantly, serum
ALT levels were reduced in P. chabaudi-infected mice treated
with anti-Ly6G to a level that was almost that of the uninfected
controls (Figure 5H). Last, neutrophil depletion resulted in a slight
increase in parasitemia after 7 days of infection (Figure 5I). These
data demonstrate that P. chabaudi infection directs neutrophil
recruitment to the liver, which, in turn, induces tissue damage.
Type I IFN Signaling Drives Neutrophil Recruitment to
the Liver
Because we observed a predominantly type I IFN transcriptional
signature in neutrophils from P. vivax-infected individuals, we
used type I IFN receptor knockout mice (IFNabR/) to investi-
gate the importance of type I IFN during malaria. Using confocal
microscopy, we observed a reduction of neutrophil recruitment
in IFNabR/ mice after 11 days of infection (Figure 6A). Wild-
type (WT) mice infected with P. chabaudi displayed a mean of
284.1 ± 13.4 (± SEM) neutrophils per 103 FOV, whereas the
average count in IFNabR/ mice was 168.6 ± 9.7 neutrophils.
As predicted, based on this reduction in neutrophil recruitment,
the ALT levels were reduced significantly in IFNabR/ mice to
levels that were comparable with NI animals (Figure 6A).
To confirm that type I IFNs are inducing liver cells from
P. chabaudi-infected mice, we analyzed, by qPCR, the expres-
sion of ISGs in WT and IFNabR/ mice. We found that IFI44,
IRF7, and IFIT1 were upregulated after P. chabaudi infection in
WT mice but not induced in IFNabR/ mice (Figure 6B). We
next decided to investigate whether the reduction in neutrophil
recruitment in type I IFN receptor knockouts may be accounted
for by a reduction in chemokines. Total mRNA was extracted
from livers of NI and infected WT and IFNabR/ mice over the
course of infection (days 3, 7, and 11). The loss of type I IFN
signaling resulted in a marked decrease in the expression of
CCL3, CXCL1, and IL-1b mRNA after P. chabaudi infection
(Figure 6C). Therefore, our data suggest that type I IFN signaling
triggers liver immunopathology during P. chabaudi infection by
inducing the expression of chemokines and IL-1b involved in
neutrophil recruitment.
When we detected a modulation of IL-1b mRNA by type I IFN
signaling, we used Caspase-1/11 knockout mice (Casp1/11/)
to study neutrophil recruitment to the liver. CD11b+Ly6CintLy6G+
cells and serum ALT levels were significantly lower in
P. chabaudi-infected Casp1/11/ mice (Figure 6D; Figure S6),
strongly suggesting a relationship between the relative neutro-
penia observed in knockout (KO) mice and the concomitant
hepatitis as well as the conclusion that Caspases 1 and 11 are
important components of liver damage.
DISCUSSION
The overt symptoms of malaria are due to the activation of
innate immune cells and subsequent systemic inflammation.
Indeed, when left untreated, malaria can be life-threatening.
P. falciparum is responsible for most cases of severe malaria,
whereas P. vivax is a relatively benign disease. However, despite
its reputation for being milder, P. vivaxmalaria is not only incapa-
citating but has been reported to occasionally cause severe
illness with complications that include acute lung injury, respira-
tory distress, severe thrombocytopenia, and severe anemia
(Alexandre et al., 2010; Baird, 2013). Hepatic damage has also
been described in both P. falciparum and P. vivax malaria (Ko-
char et al., 2010; Whitten et al., 2011), but the mechanisms of
how malaria induces liver injury is poorly understood.
It is the common view that liver pathology during malaria infec-
tion is associated with hemolysis of infected red blood cells and
the subsequent host inflammatory response to the products
released from these infected cells. In animal models, elevated
production of IFN-g and IL-12 (Yoshimoto et al., 1998) and
augmented infiltration of CD1d-unrestricted natural killer T
(NKT) cells were associated with liver injury (Adachi et al.,
2004). The most commonly held view seems to be that malaria
causes a brisk hemolysis and that leukocyte recruitment to the
liver subsequently results from immune activation because of
the recognition of the products of erythrocytes. In turn, there is
increased mRNA expression of adhesion molecules and chemo-
kines in liver cells (Dey et al., 2012).
Although our data concerning transaminasemia do not neces-
sarily contradict this idea, our view is that the hepatic neutrophils
are actually the cause, and not the result, of hepatic injury.
Indeed, in infectious disorders, neutrophils are typically the first
cells to migrate to inflammatory sites, where they fight invasive
pathogens (Nathan, 2006). However, the activation of neutro-
phils, even when appropriate, may contribute to tissue damage
during excessive inflammatory reactions (Marques et al., 2015b).
During the course of malaria, hepatitis and transaminasemia
are extremely common but rarely considered to be clinically
important, at least with respect to serious morbidity and mortal-
ity. However, given the systemic nature of malaria, it is likely that
what can be seen on the surface of the liver by intravital micro-
scopy is happening in other organs as well. Neutrophil-mediated
injury to the vascular surface of post-capillary venules, the kid-
ney, and other sites of importance in life-threatening malaria
might, in fact, result in an enhancement of the seriousness of
infection. Unfortunately, like so many other aspects of innate im-
munity in malaria, there is only limited evidence to support this
hypothesis. For example, early neutrophil depletion prevents
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the symptoms of cerebral malaria in mice by decreasing mono-
cyte sequestration to the brain (Chen et al., 2000). However, this
study used amonoclonal antibody (clone RB6-8C5) that also de-
pletes dendritic cells and subpopulations of lymphocytes and
monocytes (Daley et al., 2008), which makes interpretation of
the results more complicated. Another tantalizing result was a
report that Plasmodium berghei ANKA induces high-affinity
immunoglobulin E receptor (FcεRI) expression in neutrophils
Figure 6. Type I IFN Signaling and Caspase 1/11 Function Mediate Neutrophil Recruitment to P. chabaudi-Infected Livers
(A) Representative images of intravital microscopy of bright-field (bottom) and neutrophil staining with anti-GR1 (top) in liver sinusoids from P. chabaudi-infected
or non-infectedWT and IFNabR/mice. Scale bars, 100 mM (top) and 200 mM (bottom). Right: quantification of GR1-positive cells from at least four fields of view.
The results are representative of two independent experiments (n = 4). Data are represented as mean ± SD (top). Serum ALT levels were measured after
P. chabaudi infection and in non-infected WT and IFNabR/ mice (n = 4). Data are represented as mean ± SEM.
(B and C) mRNA expression of (B) the interferon-stimulated genes IFI44, IRF7, and IFIT1 and (C) the cytokines and chemokines IL-1b, CCL3, and CXCL1 in the
livers of WT and IFNabR/ mice infected with P. chabaudi at different time points (3 days, 7 days, and 11 days) or left untransfected. Data are presented as a
mean ± SEM of normalized expression to the GAPDH level of three biological replications. The differences are relative toWTmice. **p < 0.01, ***p < 0.001, ****p <
0.0001. See also Table S4.
(D) Absolute numbers of CD11b+Ly6CintLy6G+ cells (left) and serum ALT levels (right) from NI and P. chabaudi-infected, WT, and Casp1/11/ mice. Data are
represented as mean ± SEM (n = 8).
See also Figure S6.
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and that activated neutrophils migrate to the brain and mediate
cerebral malaria (Porcherie et al., 2011).
An interesting observation we made is that P. vivax infections
result in high circulating levels of activated low-density granulo-
cytes, which is consistent with the hypothesis that neutrophils
are activated during malaria. Low-density granulocytes have
been reported in systemic lupus erythematosus (SLE) (Denny
et al., 2010), HIV (Cloke et al., 2012), and psoriasis (Lin et al.,
2011) and in certain types of cancer (Brandau et al., 2011; Rodri-
guez et al., 2009). The origin and activation status of LDGs
are controversial because of differences found in nuclear
morphology and the expression of surface markers (Brandau
et al., 2011; Denny et al., 2010). Our results indicate that LDGs
aremature cells based on their surface activationmarker expres-
sion, once they do not express markers of neutrophil progeni-
tors. Although the LDGs fromP. vivax-infected patients resemble
the granulocytic/neutrophilic MDSCs in terms of surface marker
expression, they did not inhibit T cell proliferation (Brandau et al.,
2011; Rodriguez et al., 2009). Therefore, we propose that LDGs
from P. vivax-infected patients are highly activated degranulated
neutrophils and major contributors to systemic inflammation.
We have reported previously that PBMCs have a type I IFN
signature in patients with uncomplicated P. falciparum malaria
(Sharma et al., 2011). This report expands upon that observation
because we demonstrated a similar interferon signature in
neutrophils during malaria. A similar pattern of gene expression
has been reported in PMNs from active tuberculosis (TB) pa-
tients and correlates with disease severity, supporting a role of
type I IFN in TB pathogenesis (Berry et al., 2010). The observa-
tion that ISG expression in neutrophils correlates with hepatic
damage in P. vivax malaria patients suggests that neutrophils
are migrating to the liver. Consistently, we found an enhanced
expression of CCR5 and migration toward a CCL3 gradient in
activated neutrophils from P. vivax patients.
Importantly, a high frequency of hemozoin-containing neutro-
phils is seen in the circulation of patients with high parasitemia
and severe disease (Lyke et al., 2003). Indeed, our results sug-
gest that neutrophils may also contribute to control parasitemia
in P. vivax-infected patients. Therefore, we observed an
augmented phagocytosis of PvRET and ROS production by neu-
trophils fromP. vivax patients. These results are consistent with a
study showing that neutrophils from periodontitis patients dis-
played an ISG signature that is associated with enhanced ROS
production (Wright et al., 2008). In agreement with our results
demonstrating that neutrophil depletion results in a small in-
crease in parasitemia of mice infected with P. chabaudi, these
studies suggest that neutrophils may play a role in resistance
to human malaria.
We then decided to investigate the role of type I IFN signaling
and neutrophils in a malaria experimental model. We found
that type I IFN promotes neutrophil migration to the liver in
P. chabaudi-infectedmice. Consistent with this, previous reports
have demonstrated that type I IFN signaling promotes leukocyte
recruitment to the liver during the pre-erythrocytic stage of
malaria (Liehl et al., 2014; Miller et al., 2014).
Furthermore, we found that caspase-1/11 was also necessary
to mediate neutrophil recruitment to the liver. Malarial Hz has
been shown to activate the NLRP3 and absent in melanoma
(AIM2) inflammasome and to trigger IL-1b production (Kalantari
et al., 2014; Shio et al., 2009). In addition, Hz also induces
mRNA expression of several chemokines such as CCL3,
CCL4, and CXCL2 in the liver (Jaramillo et al., 2004). Taking
into consideration our own results and those published else-
where, we propose that type I IFN promotes the expression of
caspase-1/11 in the liver, which generates active IL-1b, a potent
inducer of chemokines that effectively recruits neutrophils.
In conclusion, our results show a pronounced expression of
activation markers, transcriptional signature of ISGs, increased
phagocytic activity, enhanced release of reactive oxygen spe-
cies and myeloperoxidase, and high circulating levels of LDGs
during P. vivax malaria. Although there is recent literature sug-
gesting ‘‘innate immunity memory’’ or ‘‘trained immunity,’’ this
interpretation implies that this stage of augmented response to
microbial stimuli is long-lasting (Quintin et al., 2014). Because
neutrophils are short-lived cells and the observed effect comes
to baseline (similar to HDs) after treatment, we favor the hypoth-
esis of neutrophil priming rather than innate immunity memory or
‘‘trained immunity.’’ Importantly, our results indicate a potential
pathophysiological role for neutrophils in liver damage during
malaria. Therefore, there is a need to look more closely at the
role of neutrophils in the multiorgan dysfunction that accom-
panies truly severe disease.
EXPERIMENTAL PROCEDURES
Patients
This study was reviewed and approved by the Ethical Committees on Human
Experimentation from Centro de Pesquisas em Medicina Tropical (CEP-
CEPEM 096/2009), the Brazilian National Ethical Committee (CONEP 15653)
of theMinistry of Health, and by the Institutional Review Board from the Univer-
sity of Massachusetts Medical School (IRB-ID11116_1). Patients with acute
uncomplicated P. vivaxmalaria (n = 44) were enrolled based on their symptoms
of fever and/or rigors in the last 24 hr before recruitment in the outpatient
malaria clinic in Porto Velho (Table S2). Written informed consent was obtained
before enrollment of all subjects. Up to 100 ml of peripheral blood was
collected immediately after confirmation of P. vivax infection by a standard
thick blood smear and 30–45 days after chemotherapy. Patients were treated
with chloroquine and primaquine according to the Brazilian Ministry of
Health, and all patients included in this study were parasitologically cured after
treatment. Peripheral blood was also collected from healthy donors living in an
endemic area and negative for P. vivax infection.
Purification of Neutrophils and Low-Density Granulocytes and Flow
Cytometry Analysis
Neutrophils from P. vivax-infected patients before and after treatment and
from HDs were isolated by Ficoll-Hypaque (GE Biosciences) gradient followed
by use of a human neutrophil enrichment kit (STEMCELL Technologies) ac-
cording to the manufacturer’s instructions. Neutrophil purity was assessed
by flow cytometry staining with the specific monoclonal antibodies listed in
Table S3. LDGs were purified from PBMCs of P. vivax-infected patients with
the CD66abce microbead kit (Miltenyi Biotec). LDGs were also analyzed by
flow cytometry within PBMCs using forward scatter height (FSC-H) and
SSC-H and specific monoclonal antibodies (mAbs) (Table S3). Stained cells
were acquired using a FACSCan upgraded with a second laser (five colors)
with Cellquest Pro and Rainbow from Cytek (BD Biosciences). Data analysis
was carried out using FlowJo version 9.4.10.
Phagocytosis and Enrichment of PvRETs
Enrichment of PvRETs was performed using a 45% Percoll gradient as
described previously (Carvalho et al., 2010). uRBCs were used as a negative
control in the phagocytosis assay. The purity of PvRETs was determined by
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optic microscopy. Purified PvRETs and uRBCs were stained with 1 mMCFSE.
Purified neutrophils and LDGs from P. vivax-infected patients were incubated
for 1 hr at 37C, 5% CO2 with purified PvRETs or uRBCs labeled previously
with CFSE (neutrophil or LDG:PvRET or uRBC ratio, 2:1). The frequencies of
neutrophils and LDGs positive for CFSE were determined by flow cytometry.
Chemotaxis Assay
Seventy-five thousand purified neutrophils and LDGs from P. vivax-infected
patients and neutrophils from HDs were allowed to migrate through a 5-mm
pore size, 96-well microchamber (NeuroProbe) toward CCL3 (50 ng/ml), IL-8
(CXCL8, 10 ng/ml), or medium alone. Migrated cells were counted under a light
microscope.
T Cell Proliferation Assay
PBMCs from P. vivax-infected patients after depletion of LDGs were harvested
and stained with 1 mMCFSE (Invitrogen). These cells were stimulated with sol-
uble aCD3 (1 mg/ml) and aCD28 (0.5 mg/ml) in the presence or absence of
LDGs or neutrophils (PBMC:LDG or neutrophil ratio, 2:1). After 4 days of cocul-
ture, CFSE fluorescence intensity was analyzed by FlowJo version 9.4.10.
T cell proliferation was determined after gating the CD3+ population and
measuring the percentage of CFSElow T cells.
Nanostring Analysis
Purified human neutrophils and LDGs were lysed in RLT buffer (QIAGEN)
supplemented with b-mercaptoethanol and used to determine mRNA abun-
dance by nanostring technology (Geiss et al., 2008). In brief, lysates were hy-
bridized with the capture and reporter probes overnight at 65C. Then they
were loaded onto the nCounter prep station and quantified with the nCounter
digital analyzer. For side-by-side comparisons of nCounter experiments,
data were normalized with internal positive controls and with seven house-
keeping genes. Finally, data from P. vivax-infected cells were normalized
to the same cells 30–45 days after treatment. Differences in gene expression
between the two conditions were considered significant when p < 0.05, as
defined by multiple t test followed by the false discovery rate approach,
and when the fold change was greater than 1.8. The heatmap was con-
structed using log2-transformed data and Tiger Multi Experiment Viewer soft-
ware version 4.8.
ROS Detection and MPO Quantification
For luminol-based ROS measurements, 5 3 105 neutrophils from P. vivax-in-
fected patients or HDs were plated in clear-bottomed 96-well plates (Corning)
in triplicate. Cells were stimulated with 100 ng/ml PMA, 2.5 3 105 PvRETs, or
left untreated with medium for 2 hr in the presence of 100 mM luminol. Where
indicated, the ROS production inhibitor DPI (5 mM) was added to the cell cul-
ture 30 min before stimulation. Chemiluminescence kinetics were measured
by Synergy HT (BioTek Instruments) microplate reader.
Onemillion purified neutrophils fromP. vivax–infected individuals before and
after treatment were stimulated with 100 ng/ml of PMA or left untreated for
24 hr. Supernatants were collected, and MPO levels were measured by an
MPO ELISA kit (Calbiochem) according to the manufacturer’s instructions.
Mice, Parasites, and Infection
C57BL/6, 129 Svev, IFNabR/, and Casp1/11/mice (8–12 weeks old) were
bred and maintained under specific pathogen-free conditions in accordance
with Institutional Animal Care and Use Committee (IACUC) guidelines. All pro-
tocols developed for this work were approved by the IACUC at the University
of Massachusetts Medical School (ID-1369-11) and by the Council of Animal
Experimentation of Oswaldo Cruz Foundation (CEUA protocol 61/13-2).
The P. chabaudi chabaudi AS strain was used for experimental infections.
This strain was maintained in C57BL/6 mice by intraperitoneal injection of
1 3 105 infected erythrocytes (iRBCs) once a week. Parasitemia was
checked every 3 days.
Quantification of Liver Neutrophils
Mouse primary nonparenchymal cells were purified from P. chabaudi-
infected and NI mice using a 35% Percoll gradient followed by red blood
cells lysis, as described before (Liehl et al., 2014). Viable nonparenchymal
cells were counted by trypan blue exclusion and stained with specific
mAbs (Table S3) to determine the frequency of neutrophils among liver
leukocytes by flow cytometry. Stained cells were acquired using an LSRII
flow cytometer (BD Biosciences). Data analysis was carried out using FlowJo
version 9.4.10.
P. chabaudi-infected and NI mice were also used for confocal intravital
microscopy neutrophil quantification as described previously (Marques et al.,
2015a). Phycoerythrin (PE)-conjugated anti-GR1 (4 mg/mouse, 40 mg/ml,
eBioscience) was injected intravenously (i.v.) 10 min before imaging. Images
were obtained using a C2 Eclipse Ti confocal microscope. Neutrophil counts
were performed using ImageJ software.
Neutrophil Depletion and ALT Measurement
In vivo neutrophil depletion was performed by administering four intraperito-
neal (i.p.) injections of anti-Ly6G antibody (500 mg/dose, clone 1A8, BioXCell)
or an isotype control (500 mg/dose, clone 2A3, BioXCell): 1 day before
P. chabaudi infection and 2, 6, and 10 days after infection. Serum ALT activity
was performed using a kinetic test (Bioclin).
qRT-PCR Analysis
Total RNA from livers of non-infected (control), 3 day-, 7 day-, or 11 day-in-
fected mice were isolated by TRIzol reagent (Invitrogen). Quantitative PCR
was carried out with the Platinum SYBR Green protocol (Invitrogen) on an
Applied Biosystems 7500 real-time PCR system using the primers listed in
Table S4. Relative quantification was performed using standard curve anal-
ysis, and the expression data were presented as the mean of normalized
expression to the GAPDH level of three biological replications.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6 software. The
results were analyzed using two-tailed paired t test and one-way ANOVA
between the groups. Mann-Whitney (MW) test was used when the data did
not fit a Gaussian distribution. The data shown are representative of at least
two independent experiments. Differences were considered to be statistically
significant when p% 0.05.
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